Interventional Platform study investigating the impact of digital health solutions on health outcomes and health care resource utilization in participants receiving systemic treatment in clinical practice (ORIGAMA)

ORIGAMA (MO42720)

Comprehensive Cancer Center Mainfranken

Bösartige Erkrankungen des unteren Verdauungstraktes (Darm, Leber/Gallenblase, Pankreas)

Leber (Hepatozelluläres Karzinom, HCC) / Gallenblase-/wege (Cholangiozelluläres Karzinom, CCC)

Lungentumoren

Kleinzelliges Bronchialkarzinom (SCLC)

Nicht-kleinzelliges Bronchialkarzinom (NSCLC)

EGFR

PD-1 (Programmed cell death protein 1)

PD-L1

Phase II/III

Herr Dr. Manfred Welslau

Frau Dr. Claudia Koch-Horn

Hämato-Onkologische Schwerpunktpraxis (MVZ) am Klinikum Aschaffenburg Dr. Welslau

Therapeutisch